Brief: HLS Therapeutics Comments On U.S. Court Of Appeals Decision In Amarin Patent Litigation
03/09/2020 18:30
Sept 3 (Reuters) - HLS Therapeutics Inc HLS.TO :
* HLS THERAPEUTICS COMMENTS ON U.S. COURT OF APPEALS
DECISION IN
AMARIN PATENT LITIGATION
* HLS THERAPEUTICS INC - AFFIRMS LITIGATION AND JUDGMENT DO
NOT
IMPACT VASCEPA IN CANADA
Source text for Eikon: ID:nCNW3yPXWa
Further company coverage: HLS.TO
((Reuters.briefs@thomsonreuters.com;))
Recent news on HLS Therapeutics
See all newsBrief: Hls Therapeutics Increases Normal Course Issuer Bid
Brief: HLS Therapeutics Announces Q2 2026 Financial Results
Canada's HLS Therapeutics Q2 revenue rises on higher cardiovascular drugs demand
Brief: HLS Therapeutics - Secures Nilemdo Reimbursement With Private Payers Covering 80% Of Privately Insured Canadians
Canada Research Roundup: CIBC ,HLS Therapeutics, TD Bank Group